The technology used in the Meril Eximo, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★★ Recommendation||Recent clinical validation; recent protocol|
|MDR Criteria||Professional use||Published evidence|
Chandnani SR, Ramakrishna CD, Dave BA, Kothavade PS, Thakkar AS. A Post-Marketing Surveillance Study to Evaluate Performance of the EXIMO™ Blood Glucose Monitoring System. J Clin Diagn Res. 2017 May;11(5):FC29-FC32. Epub: 2017 May 1. doi: 10.7860/JCDR/2017/26596.9892. PMID: 28658800. Available from: PMC5483702.
15197:2013 - Pass General population